Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ranolazine (ranexa) (1 trial)
Ischemia (Phase 4)
Mitral Valve Insufficiency (Phase 4)
Trials (1 total)
Trial APIs (1 total)